Emerald Health Therapeutics Completes Investment in Licensed Dealer Northern Vine
November 21, 2017 07:00 ET
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics Inc. (“Emerald”) (TSX-V:EMH) (OTCQX:EMHTF) announced today that it has completed its previously announced...
Emerald Health Therapeutics Appoints Robert C. Hill, CPA, CA as Chief Financial Officer and Promotes Cheryl Evans, CPA, CA to Vice President Finance
November 20, 2017 08:30 ET
|
Emerald Health Therapeutics Inc.
VICTORIA, B.C., Nov. 20, 2017 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics Inc. (TSXV:EMH) (OTCQX:EMHTF) (“Emerald”) today announced the appointment of Robert C. Hill, CPA, CA, as the Company's...
Emerald Health Therapeutics Announces Positive Health Canada Review of its Licensed Producer Application for Pure Sunfarms Facility
November 13, 2017 08:00 ET
|
Emerald Health Therapeutics Inc.
RICHMOND, British Columbia, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics Inc. (TSXV:EMH) (OTCQX:EMHTF) announced today that its licensed producer application for the Pure Sunfarms...
Emerald Health Therapeutics Engages Investor Relations Consultant and Grants Stock Options
November 02, 2017 17:48 ET
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF) ("Emerald" or the “Company”) announces that Emerald Health Sciences Inc....
Emerald Health Therapeutics to Acquire Control of Licensed Dealer Northern Vine
October 26, 2017 08:00 ET
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, Oct. 26, 2017 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics Inc. (“Emerald”) (TSXV:EMH) (OTCQX:EMHTF) announced today that it has signed a definitive agreement (the...
Emerald Health’s Two Cannabis Production Expansion Sites Progressing for Legalized Adult-Use Market in 2018
October 18, 2017 07:00 ET
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, Oct. 18, 2017 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics Inc. (“EHT”) (TSXV:EMH) (OTCQX:EMHTF), through Emerald Health Botanicals Inc. ("Emerald"), its wholly owned...
Emerald Health Therapeutics Appoints Pharmaceutical Marketing and Biotech Executive Chris Wagner as CEO
October 02, 2017 07:00 ET
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, Oct. 02, 2017 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics Inc. (“EHT”) (TSXV:EMH) (OTCQX:EMHTF) is pleased to announce the appointment of Chris Wagner as Chief...
Emerald Health Therapeutics’ Scientific Advisors Publish Research Discovery of THCA Cannabinoid’s Neuroprotective Treatment Potential
September 20, 2017 07:00 ET
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, Sept. 20, 2017 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics Inc. (EHT) (TSXV:EMH) (OCTQX:EMHTF), a Canadian licensed medical producer of cannabis, is pleased to report...
Emerald Health Therapeutics Expands its Cannabis Supply with Purchase from Supreme Pharmaceuticals
September 19, 2017 18:10 ET
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics Inc. (EHT) (TSXV:EMH) (OCTQX:EMHTF) today announced that its wholly owned subsidiary, Emerald Health...
Emerald Health Therapeutics Launches Island Mist, One of Canada’s Highest CBD and CBD to THC Ratio Dried Flower Products
September 18, 2017 07:00 ET
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics Inc. (Therapeutics) (TSX-V:EMH) (OCTQX:EMHTF) has released Island Mist, its proprietary high cannabidiol...